— Know what they know.
Not Investment Advice

DMAA NASDAQ

Drugs Made In America Acquisition Corp. Ordinary Shares
1W: +0.4% 1M: +1.1% 3M: +2.1% YTD: +4.8% 1Y: +6.0%
$10.88
-0.01 (-0.09%)
 
Weekly Expected Move ±0.3%
$11 $11 $11 $11 $11
NASDAQ · Financial Services · Shell Companies · Tech Score Buy · Power 48 · $264.1M mcap · 19M float · 0.160% daily turnover · Short 48% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$6M
Net Income
+72.0% YoY
$-0M
Free Cash Flow
+41.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE3.3%
ROA3.2%
ROIC-1.9%

Valuation

P/E55.4
P/B1.6
EV/EBITDA-81.6

Leverage

Debt/Equity0.01
Current Ratio0.02
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z13.90
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms